The healthcare distribution market is projected to grow at a CAGR of 6.5% during the forecast period of 2019 to 2024 The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024 from USD 765.4 billion in 2019, at a CAGR of 6.5%. The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry. In addition, emerging markets such as China and India, growth in the biosimilars market, increasing specialty drug dispensing, and the rising uptake of biopharmaceuticals are expected to offer potential growth opportunities to market players in the coming years. However, increasing pricing pressure is a major challenge faced by market players.
Pharmaceutical product distribution services segment is expected to account for the largest share of the healthcare distribution market, by type, in 2018 Based on type, the healthcare distribution market is segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In 2018, the pharmaceutical product distribution services segment accounted for the largest share of this market owing to the increasing production of pharmaceutical formulations, rising pharmaceutical R&D expenditure, outsourcing of pharmaceutical manufacturing to Asian countries, and the establishment of new manufacturing facilitates by global pharmaceutical giants in newer geographies.
Retail pharmacies segment to dominate the healthcare distribution market, by end user, during the forecast period The retail pharmacies segment accounted for the largest share of the market in 2018.These pharmacies deal with a large volume of prescriptions on a daily basis.
Moreover, in the US and other developed countries, the implementation of programs to ensure affordable healthcare for citizens has significantly increased the volume of prescriptions in retail pharmacies.
APAC market to witness the highest growth during the forecast period North America accounted for the largest share of the global healthcare distribution market in 2018, followed by Europe.However, the APAC market is estimated to grow at the highest CAGR during the forecast period.
This can primarily be attributed to the growing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing and distribution practices and the rising number of pharmaceutical and biotechnology companies in the region. China and India are the fastest-growing markets in this region primarily due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs (as they move from manufacturing to the consumer).
A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20% • By Designation: C-level – 43%, Director-level – 32%, and Others – 25% • By Region: North America – 38%, Europe – 29%, Asia Pacific – 23%, and the Rest of the World – 10%
The prominent players operating in this market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).
Research Coverage: This report analyzes the healthcare distribution market and aims at estimating the size and future growth potential of this market as well as its segments. The report also includes an in-depth competitive analysis of the key players operating in this market, along with their company profiles, solution & service offerings, and recent developments.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence. • Market Penetration: Comprehensive information on the solution/service portfolios offered by the top players in the healthcare distribution market • Solution & Service Development/Innovation: Detailed insights on the upcoming trends, and solution and service launches in the healthcare distribution market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new solutions and services, growing geographies, and recent developments in the global healthcare distribution market • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and solution & service offerings of the leading players operating in the healthcare distribution market
Our reports have been used by over 10K customers, including:
The global epinephrine market is expected to reach US$ 4,207.88 Mn in 2027 from US$ 2,247.87 Mn in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027. The growth of the epinephrine market is estimated to due to driving factors such as increasing anaphylaxis cases and introduction of generic version of epinephrine...
Hepatocyte Growth Factor - Pipeline Review, H1 2020 Summary Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. The latest report Hepatocyte Growth Factor - Pipeline Review, H1 2020, outlays comprehensive information on the Hepatocyte...
Rising focus on the analytical testing of biologics and biosimilars to drive market growth The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is attributed to the rising focus...
The healthcare analytical testing services market is projected to grow at a CAGR of 11.4%. The global healthcare analytical testing services market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4% during the forecast period. Market growth is attributed to the shift of focus towards the...
The Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal...
243 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Biologics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.